Clinical trial
Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid…
NCT00137891 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00137891 |
|---|---|
| Title | Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone |
| Official title | Phase I Study Comparing Pharmacokinetics and Safety Profile of Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Modified Release rhTSH |
| Enrollment | 46 |
| Start date | Jun 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Aug 30, 2005 |
| Last update posted | Mar 18, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: